Stéphane Bancel

Net Worth

$1.353B

+0.99% (24h)

Stéphane Bancel, a French-born business executive, is the Chief Executive Officer of Moderna, a prominent biotechnology company. His leadership has been instrumental in the development of mRNA-based vaccines, including the COVID-19 vaccine. Bancel's career includes executive positions at BioMérieux and Eli Lilly and Company. His net worth is estimated at $1.2 billion as of 2024, stemming from his stake in Moderna. He resides in Boston, Massachusetts, and holds degrees from École Centrale Paris, the University of Minnesota, and Harvard Business School.

The Full Dossier

Early Life

Stéphane Bancel was born in Marseille, France, on July 20, 1972. Growing up, he developed an interest in science and mathematics. His father was an engineer, and his mother was a doctor, which may have influenced his interest in STEM fields.

Career

Bancel's professional journey began at Eli Lilly and Company, where he progressed to Head of Operations for Belgium. He then served as the CEO of BioMérieux, a French diagnostics company, where he improved the company's margins. In 2011, Bancel became the CEO of Moderna. Under his leadership, Moderna has become a leader in mRNA-based therapeutics and vaccines, particularly the COVID-19 vaccine. He is also a partner at Flagship Pioneering.

Key Business Strategies

Bancel's strategies have focused on developing mRNA technology. Moderna's key achievements include the development and commercialization of the COVID-19 vaccine, which gained FDA approval. The company has expanded its research to include cancer vaccines and treatments for other diseases. Bancel owns a significant stake in Moderna.

Philanthropy

In 2023, Bancel announced he would donate proceeds from selling Moderna shares to charity.

Career Timeline

2011

CEO of Moderna

Led Moderna's development of mRNA-based therapeutics, including the COVID-19 vaccine.

2007

CEO of BioMérieux

Improved the company's margins.

2000

Various Roles at Eli Lilly

Held positions including Managing Director, Belgium, and Executive Director, Global Manufacturing Strategy and Supply Chain.

Philanthropic Impact

General$XB

Charitable Donations

Donating proceeds of selling Moderna shares to charity.